Item Details
VaxThera Secures Vaccine Manufacturing Agreement
On 2 November, South Korea’s GC Biopharma signed a 59.2 billion won agreement with Colombia’s VaxThera for influenza-vaccine materials and production expertise. The deal creates opportunities in pharmaceutical manufacturing, packaging and distribution. HPC can help identify qualified healthcare suppliers and commercial partners.
Get in Touch
We’ll get back to you shortly.